In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST.
Dr. Bialick was joined by caregiver Stacey Stevens who shared her perspective on ctDNA in the diagnostic process.
About Our Presenter:
Steven Bialick, DOSylvester Comprehensive Cancer Center, Miami
Steve Bialick, DO, is a hematology/oncology fellow at Jackson Memorial Hospital and the University of Miami/Sylvester Comprehensive Cancer Center in Miami, FL. He completed his internal medicine residency within the University of Pennsylvania Health System before working as a hematologic malignancy hospitalist at the Hospital of the University of Pennsylvania in Philadelphia, PA. He is now completing his oncology training with a focus on solid tumor malignancies, specifically soft tissue and bone sarcomas. His research interests include hereditary cancer predisposition syndromes, circulating tumor DNA and its role in guiding targeted therapies, and the role of DNA damage repair pathways in sarcomas.
